Wedmont Private Capital »

Recursion Pharmaceuticals shares owned by Wedmont Private Capital

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Wedmont Private Capital from 13F filings

Historical chart of Wedmont Private Capital investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Wedmont Private Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Wedmont Private Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $172k 19k 9.09
2023-12-31 $214k 17k 12.61
2023-09-30 $115k 17k 6.76
2023-06-30 $202k 17k 11.90

More positions owned by Wedmont Private Capital

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Total Corp Bnd (VTC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
NVIDIA Corporation (NVDA)
Ishares Tr National Mun Etf (MUB)
Amazon (AMZN)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)

View all positions for Wedmont Private Capital

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
MIC Capital Management UK
Nvidia Corp
Norges Bank Investment Management
Dimensional Fund Advisors
Credit Suisse
Point72 Asset Management
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Recursion Pharmaceuticals